Memorializing Governor Kathy Hochul to proclaim March 20, 2026, as Ameloblastoma Day in the State of New York
Summary
Assembly Resolution 1071 is a ceremonial resolution that memorializes Governor Kathy Hochul to proclaim March 20, 2026, as Ameloblastoma Day in New York State. The resolution explains that ameloblastoma is a rare head and neck tumor that usually develops in the jaw, is often benign and slow-growing, but can be locally destructive, recur, and in rare cases become malignant. It emphasizes that the condition can go unnoticed for some time and may pose serious health risks if untreated.
The purpose of the resolution is to raise public awareness of ameloblastoma and to recognize people living with the condition. By designating a day of awareness, the measure seeks to encourage earlier recognition of symptoms and reduce potential complications associated with delayed diagnosis or treatment. The resolution does not create a regulatory program, funding mechanism, or clinical mandate; it is a formal request for a gubernatorial proclamation and a symbolic observance.
Impact
This resolution has no direct effect on the New York Consolidated Laws and does not amend any statute. Its practical impact is limited to public recognition and awareness-raising around a rare disease, with the intended audience including patients, families, healthcare providers, and the broader public. The only formal action requested is that the Governor issue a proclamation designating March 20, 2026, as Ameloblastoma Day.
Sentiment
The overall sentiment reflected in the bill text is strongly supportive and commemorative. The resolution frames the observance as consistent with the Legislature’s tradition of recognizing awareness days that promote public wellbeing. Because there are no committee transcripts or recorded votes, there is no evidence of opposition or debate in the available record, and the measure appears to be noncontroversial and unanimously celebratory in tone.
Contention
There are no notable points of contention in the available materials. The resolution is symbolic rather than substantive, so it does not raise fiscal, regulatory, or enforcement issues. Any discussion implied by the text centers on the value of awareness for a rare medical condition, rather than disagreement over policy details or legal consequences.